These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1175309)

  • 41. The effect of carbimazole following radioiodine therapy on radiation dose to the thyroid.
    Gimlette TM; Kocak R; Herbert RG; Squire CR
    Nuklearmedizin; 1981 Apr; 20(2):72-5. PubMed ID: 6165965
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Defects in intrathyroid binding of iodine and the perchlorate discharge test.
    Hilditch TE; Horton PW; McCruden DC; Young RE; Alexander WD
    Acta Endocrinol (Copenh); 1982 Jun; 100(2):237-44. PubMed ID: 6287779
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Retarded incorporation of [14C]mannose into thyroglobulin of human thyrotoxic thyroid glands.
    Thomson JA; Baird SG
    Clin Endocrinol (Oxf); 1976 Sep; 5(5):485-93. PubMed ID: 991432
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intrathyroidal iodide binding rates and plasma methimazole concentrations in hyperthyroid patients on small doses of carbimazole.
    Low LC; McCruden DC; Alexander WD; Hilditch TE; Skellern GG; Knight BI
    Br J Clin Pharmacol; 1981 Sep; 12(3):315-8. PubMed ID: 7295461
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lugol's iodine: its effect on thyroid blood flow in patients with thyrotoxicosis.
    Marigold JH; Morgan AK; Earle DJ; Young AE; Croft DN
    Br J Surg; 1985 Jan; 72(1):45-7. PubMed ID: 3967130
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A study of long acting propranolol in the early management of hyperthyroidism.
    Jones GR; Lazarus JH; Wynford-Thomas D
    Br J Clin Pharmacol; 1981 Dec; 12(6):825-8. PubMed ID: 7041935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. SIMS evidence that carbimazole enhances spatial heterogeneity of thyroid iodine storage and targeting in a woman with Graves' disease.
    Clerc J; Kahn E; Fragu P
    Cell Mol Biol (Noisy-le-grand); 2001 May; 47(3):519-27. PubMed ID: 11441959
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Propranolol and the utilization of radioiodine by the human thyroid gland.
    Hadden DR; Bell TK; McDevitt DG; Shanks RG; Montgomery DA; Weaver JA
    Acta Endocrinol (Copenh); 1969 Jul; 61(3):393-9. PubMed ID: 4184991
    [No Abstract]   [Full Text] [Related]  

  • 49. Propranolol in the treatment of thyrotoxicosis by subtotal thyroidectomy.
    Toft AD; Irvine WJ; McIntosh D; MacLeod DA; Seth J; Cameron EH; Lidgard GP
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1312-6. PubMed ID: 826544
    [TBL] [Abstract][Full Text] [Related]  

  • 50. 99mTc-pertechnetate for measuring thyroid suppressibility.
    Shimmins J; Alexander WD; McLarty DG; Robertson JW; Sloane DJ
    J Nucl Med; 1971 Feb; 12(2):51-4. PubMed ID: 5539590
    [No Abstract]   [Full Text] [Related]  

  • 51. The management of recurrent thyrotoxicosis after thyroidectomy.
    Baker G; Pimstone B
    S Afr Med J; 1971 Jun; 45(23):646-8. PubMed ID: 5559401
    [No Abstract]   [Full Text] [Related]  

  • 52. Preoperative treatment of thyrotoxicosis with a beta-adrenergic blocking agent.
    Ljunggren JG; Persson B
    Acta Chir Scand; 1975; 141(8):715-8. PubMed ID: 3081
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Outcome of treatment of hyperthyroidism.
    Bringmann IM; van Leeuwen BL; Hennemann G; Beckett GJ; Toft AD
    J Endocrinol Invest; 1999 Apr; 22(4):250-6. PubMed ID: 10342357
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effect of iodide on thyroidal iodine turnover in hyperthyroid subjects.
    Nagataki S; Shizume K; Nakao K
    J Clin Endocrinol Metab; 1970 Apr; 30(4):469-78. PubMed ID: 5435286
    [No Abstract]   [Full Text] [Related]  

  • 55. Radioiodine therapy in Graves' disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy.
    Sabri O; Zimny M; Schreckenberger M; Reinartz P; Ostwald E; Buell U
    Thyroid; 1999 Dec; 9(12):1181-8. PubMed ID: 10646656
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early kinetics of thyroid trap in normal human patients and in thyroid diseases.
    Bazin JP; Fragu P; Di Paola R; Di Paola M; Tubiana M
    Eur J Nucl Med; 1981; 6(7):317-26. PubMed ID: 6166476
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prediction of the long-term results of antithyroid drug therapy for thyrotoxicosis.
    Alexander WD; McLarty DG; Robertson J; Shimmins J; Brownlie BE; Harden RM; Patel AR
    J Clin Endocrinol Metab; 1970 Apr; 30(4):540-3. PubMed ID: 4190916
    [No Abstract]   [Full Text] [Related]  

  • 58. Proceedings: Thyrotoxicosis: relationship between clinical status, pituitary-thyroid function, and sex hormone-binding globulin levels on carbimazole therapy.
    Liendo-Ch P; Mortimer CH; Anderson DC; Fisher RA; Self M; Ciclitira P; Chan V; Besser GM
    J Endocrinol; 1975 Jun; 65(3):17P-18P. PubMed ID: 1151217
    [No Abstract]   [Full Text] [Related]  

  • 59. Control of severe thyrotoxicosis with potassium iodide and propranolol.
    Nicol EF; Irvine WJ
    Scott Med J; 1982 Apr; 27(2):172-4. PubMed ID: 7089529
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Technetium uptake in the management of thyrotoxicosis.
    Van't Hoff W; Pover GG; Drury PL
    Clin Endocrinol (Oxf); 1978 Apr; 8(4):327-33. PubMed ID: 647986
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.